Wirk, B. and Lim, J. (2025) “Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma”, Journal of Hematology, 14(3), pp. 146–151. doi:10.14740/jh2046.